Insulet Corp
(STU:GOV)
€
247.3
19.2 (8.42%)
Market Cap: 18.05 Bil
Enterprise Value: 18.52 Bil
PE Ratio: 47.22
PB Ratio: 17.30
GF Score: 92/100 
Insulet Corp at Wells Fargo Healthcare Conference Transcript
Sep 09, 2022 / 12:00PM GMT
Release Date Price:
€266.5
(+2.50%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
(technical difficulty) analyst at Wells Fargo. And it is my pleasure to host this session with Insulet.
With us, we have Wayde McMillan, the CFO. I'm a little winded from just running. And Deb Gordon, the Head of Investor Relations. The format is going to be a fireside chat. (Operator Instructions)
And so Wayde and Deb, thank you so much for being here.
Wayde D. McMillan
Insulet Corporation - Executive VP,CFO & Treasurer
Good morning. Good morning, everybody. Thanks for having us, Larry. Great venue here.
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Thank you.
Wayde D. McMillan;Lawrence H. Biegelsen
Insulet Corporation - Executive VP,CFO & Treasurer;Wells Fargo Securities, LLC, Research Division
Nice to be back in person.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers